Ashish Sitapara, MD P.C. – Trademark Portfolio
Entity Type: 57
Ashish Sitapara, MD P.C. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include SIGNATURE MEDICINE and SM SIGNATURE MEDICINE CENTER FOR WELLNESS & HEALTHY LIVING. The owner is based in Newtown, PA.
770 Newtown Yardley Road, Suite 220
Newtown, PA 18940
Showing of trademarks Trademarks
Trademark Classifications
Ashish Sitapara, MD P.C.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Ashish Sitapara, MD P.C. have?
Ashish Sitapara, MD P.C. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Ashish Sitapara, MD P.C. file in?
Ashish Sitapara, MD P.C. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Ashish Sitapara, MD P.C.'s most well-known trademarks?
Ashish Sitapara, MD P.C.'s registered trademark portfolio includes well-known marks such as SIGNATURE MEDICINE and SM SIGNATURE MEDICINE CENTER FOR WELLNESS & HEALTHY LIVING. These are among 2 currently registered trademarks in the portfolio.
What is Ashish Sitapara, MD P.C.'s trademark registration success rate?
Ashish Sitapara, MD P.C. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.